[HTML][HTML] An update on human papilloma virus vaccines: history, types, protection, and efficacy

Z Yousefi, H Aria, F Ghaedrahmati, T Bakhtiari… - Frontiers in …, 2022 - frontiersin.org
Human papillomavirus (HPV) is the most common sexually transmitted agent worldwide.
Early prevention with HPV vaccination is a safe and effective method against this disease …

[HTML][HTML] HPV vaccines–a review of the first decade

DM Harper, LR DeMars - Gynecologic oncology, 2017 - Elsevier
Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …

[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors

C Simoens, PPL Martin‐Hirsch - Cochrane database of …, 2018 - cochranelibrary.com
Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

[HTML][HTML] Vaccine delivery using nanoparticles

AE Gregory, R Titball, D Williamson - Frontiers in cellular and …, 2013 - frontiersin.org
Vaccination has had a major impact on the control of infectious diseases. However, there
are still many infectious diseases for which the development of an effective vaccine has …

Portfolio theory: as I still see it

HM Markowitz - Annu. Rev. Financ. Econ., 2010 - annualreviews.org
This essay summarizes my views on (a) the foundations of portfolio theory and its
applications to current issues, such as the choice of criteria for practical risk-return analysis …

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial

SRM Dobson, S McNeil, M Dionne, M Dawar, G Ogilvie… - Jama, 2013 - jamanetwork.com
Importance Global use of human papillomavirus (HPV) vaccines to prevent cervical cancer
is impeded by cost. A 2-dose schedule for girls may be possible. Objective To determine …

[HTML][HTML] Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers

L Mezache, B Paniccia, A Nyinawabera, GJ Nuovo - Modern Pathology, 2015 - Elsevier
Programmed death ligand 1 (PD L1) expression can reduce the immune response in both
infectious diseases and cancers. We thus examined PD L1 expression in cervical …

Therapeutic vaccines for HPV-associated malignancies

C Smalley Rumfield, N Roller, ST Pellom… - ImmunoTargets and …, 2020 - Taylor & Francis
Human papillomavirus (HPV)-related malignancies are responsible for almost all cases of
cervical cancer in women, and over 50% of all cases of head and neck carcinoma …

Predictors of HPV vaccine acceptability: a theory-informed, systematic review

NT Brewer, KI Fazekas - Preventive medicine, 2007 - Elsevier
OBJECTIVE.: To inform future human papillomavirus (HPV) vaccination programs, we
systematically reviewed studies of HPV-related beliefs and HPV vaccine acceptability …